Today, October 1, 2021, the project IMMOONITY – Development of a novel interferon-based therapy to treat and prevent bacterial and viral infections – sponsored by the EUREKA Eurostars grant – started.
As earlier reported an application of consortium consisted of FarmPharma (which is a coordinator of the consortium), the Karolinska Institute, and two organizations from France and Slovenia for the project which is devoted to the development of InterferOX product for sustainable treatment and prevention of viral and bacterial infections in cattle was approved and validated. Today the project officially started and a kick-off meeting with all partners of the consortium takes place.
“We are glad to start the project in accordance with our plans. The financing of EUREKA Eurostars gives us the excellent opportunity to jointly develop our product InterferOX which is a game-changer in the fight against infections in cattle”, – comments Irina Zaitseva, CEO of FarmPharma
More about FarmPharma:
FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.